Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;28(30):40507-40514.
doi: 10.1007/s11356-021-14195-9. Epub 2021 May 2.

In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes

Affiliations

In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes

Moataz A Shaldam et al. Environ Sci Pollut Res Int. 2021 Aug.

Abstract

After the early advent of the Coronavirus Disease 2019 (COVID-19) pandemic, myriads of FDA-approved drugs have been massively repurposed for COVID-19 treatment based on molecular docking against selected protein targets that play fundamental roles in the replication cycle of the novel coronavirus. Honeybee products are well known of their nutritional values and medicinal effects. Bee products contain bioactive compounds in the form of a collection of phenolic acids, flavonoids, and terpenes of natural origin that display wide spectrum antiviral effects. We revealed by molecular docking the profound binding affinity of 14 selected phenolics and terpenes present in honey and propolis (bees glue) against the main protease (Mpro) and RNA-dependent RNA polymerase (RdRp) enzymes of the novel SARS-CoV-2 virus (the causative agent of COVID-19) using AutoDock Vina software. Of these compounds, p-coumaric acid, ellagic acid, kaempferol, and quercetin have the strongest interaction with the SARS-CoV-2 target enzymes, and it may be considered an effective COVID-19 inhibitor.

Keywords: COVID-19; Drug repurposing; Honeybee products; Molecular docking; Natural products; Phenolic compounds.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Chemical structure of important bioactive compounds in honeybee products
Fig. 2
Fig. 2
The docking complex of a ellagic acid, b hesperetin, and c kaempferol (green) with the X-ray structure of 6M71; SARS-CoV-2 RNA-dependent RNA polymerase (left, tint) that showed hydrogen bond (blue) interaction and 2D schematic diagram of the interaction (right)
Fig. 3
Fig. 3
The docking complex of a artepillin C and b ellagic acid (green) with the X-ray structure of 6LU7; SARS-CoV-2 main protease (Mpro) (left, tint) that showed hydrogen bond (blue) interaction and 2D schematic diagram of the interaction (right)
Fig. 4
Fig. 4
The docking complex of a hesperetin, b kaempferol, and c quercetin (green) with the X-ray structure of 6LU7; SARS-CoV-2 main protease (Mpro) (left, tint) that showed hydrogen bond (blue) interaction and 2D schematic diagram of the interaction (right)

Similar articles

Cited by

References

    1. Al Naggar, Yahya, Sun J, Robertson A, Giesy JP, Wiseman S (2016) Chemical characterization and antioxidant properties of Canadian propolis. In J Apic Res 55(4):305–314.10.1080/00218839.2016.1233700
    1. Naggar A, Yahya, Giesy JP, Abdel-Daim MM, Ansari J, Mohammad, Al-Kahtani SN, Yahya G. Fighting against the second wave of COVID-19: can honeybee products help protect against the pandemic? In Saudi J Biol Sci. 2020;28:1519–1527. doi: 10.1016/j.sjbs.2020.12.031. - DOI - PMC - PubMed
    1. Al Naggar Y, Yahya G, Al-Kahtani S, Stangaciu S, El-Seedi H (2021) Back to Ancient Remedy: Could Inhalation of Aerosolised-Honey and Propolis Tincture Protect Against the COVID-19 Pandemic? J Apither 8(2):1–5
    1. Bafna K, Krug RM, Montelione GT (2020) Structural similarity of SARS-CoV2 Mpro and HCV NS3/4A proteases suggests new approaches for identifying existing drugs useful as COVID-19 therapeutics. In ChemRxiv. 10.26434/chemrxiv.12153615
    1. Biopharma products in development for COVID-19 (2021). Available online at https://www.bioworld.com/COVID19products, updated on 1/14/2021, checked on 1/14/2021.

Substances

LinkOut - more resources